Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ARCT 032

Next Previous
Drug Profile

ARCT 032

Alternative Names: ARCT-032; ARTC032; LUNAR CF - Arcturus Theraepeutics; LUNAR-CF; mRNA CFTR therapeutic - Arcturus Therapeutics

Latest Information Update: 01 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Arcturus Therapeutics
  • Developer Arcturus Therapeutics; Cystic Fibrosis Foundation Therapeutics
  • Class Antifibrotics; RNA
  • Mechanism of Action Cystic fibrosis transmembrane conductance regulator expression stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cystic fibrosis
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Cystic fibrosis

Most Recent Events

  • 11 Aug 2025 Arcturus Therapeutics plans meetings with US FDA and other regulatory agencies to discuss phase II data and plans for pivotal trials in Cystic fibrosis in the first half of 2026
  • 11 Aug 2025 Arcturus Therapeutics plans a phase III trial for Cystic fibrosis (Inhalation, Aerosol) in 2026
  • 12 Dec 2024 Phase-II clinical trials in Cystic fibrosis in USA (Inhalation) (NCT06747858)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top